Search Results - "Micheletto, Claudio"

Asthmatic patients in COVID-19 outbreak: Few cases despite many cases by Caminati, Marco, Lombardi, Carlo, Micheletto, Claudio, Roca, Elena, Bigni, Barbara, Furci, Fabiana, Girelli, Domenico, Senna, Gianenrico, Crisafulli, Ernesto

Get full text

Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity by Caminati, Marco, Vultaggio, Alessandra, Matucci, Andrea, Senna, Gianenrico, Almerigogna, Francesco, Bagnasco, Diego, Chieco-Bianchi, Fulvia, Cosini, Filippo, Girelli, Domenico, Guarnieri, Gabriella, Menzella, Francesco, Micheletto, Claudio, Olivieri, Oliviero, Passalacqua, Gianni, Pini, Laura, Rossi, Oliviero, Vianello, Andrea, Vivarelli, Emanuele, Crisafulli, Ernesto

“…Asthma prevalence among COVID-19 patients seems to be surprisingly low. However the clinical profile of COVID-19 asthmatic patients and potential determinants…”
Get full text

Prevalence of SARS-CoV-2, Verona, Italy, April-May 2020 by Guerriero, Massimo, Bisoffi, Zeno, Poli, Albino, Micheletto, Claudio, Conti, Antonio, Pomari, Carlo

“…We used random sampling to estimate the prevalence of severe acute respiratory syndrome coronavirus 2 infection in Verona, Italy. Of 1,515 participants, 2.6%…”
Get full text

CT radiomic models to distinguish COVID-19 pneumonia from other interstitial pneumonias by Cardobi, Nicolò, Benetti, Giulio, Cardano, Giuseppe, Arena, Cinzia, Micheletto, Claudio, Cavedon, Carlo, Montemezzi, Stefania

“…Purpose To classify COVID-19, COVID-19-like and non-COVID-19 interstitial pneumonia using lung CT radiomic features. Material and Methods CT data of 115…”
Get full text

Cost-effectiveness of consolidation durvalumab after chemo-radiotherapy in stage III non-small-cell lung cancer: A cost-effective change by Giuliani, Jacopo, Infante, Maurizio Valentino, Micheletto, Claudio, Bonetti, Andrea

Get full text

Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance by Caminati, Marco, Maule, Matteo, Benoni, Roberto, Micheletto, Claudio, Tecchio, Cristina, Vaia, Rachele, De Franceschi, Lucia, Guarnieri, Gabriella, Vianello, Andrea, Senna, Gianenrico

“…Abstract Mepolizumab at the dose of 300 mg/4 weeks has been recently approved as an add-on therapy for patients with uncontrolled hypereosinophilic syndrome…”
Get full text

Prevalence of asymptomatic SARS-CoV-2-positive individuals in the general population of northern Italy and evaluation of a diagnostic serological ELISA test: a cross-sectional study protocol by Guerriero, Massimo, Bisoffi, Zeno, Poli, Albino, Micheletto, Claudio, Pomari, Carlo

“…IntroductionAs of 30 April 2020, the novel betacoronavirus SARS-CoV-2 had infected more than 3 172 000 individuals, killing over 224 000 people and spreading…”
Get full text

Assessment of COVID-19 progression on day 5 from symptoms onset by Gentilotti, Elisa, Savoldi, Alessia, Compri, Monica, Górska, Anna, De Nardo, Pasquale, Visentin, Alessandro, Be, Giorgia, Razzaboni, Elisa, Soriolo, Nicola, Meneghin, Dario, Girelli, Domenico, Micheletto, Claudio, Mehrabi, Sara, Righi, Elda, Tacconelli, Evelina

“…A major limitation of current predictive prognostic models in patients with COVID-19 is the heterogeneity of population in terms of disease stage and duration…”
Get full text

Clinical characteristics, use and switch of drugs for obstructive airway diseases among patients with COPD experiencing an exacerbation: a retrospective analysis of Italian administrative healthcare data by Dondi, Letizia, Ronconi, Giulia, Calabria, Silvia, Dell'Anno, Irene, Dondi, Leonardo, Piccinni, Carlo, Brignoli, Ovidio, Canonica, Giorgio Walter, Carone, Mauro, Di Marco, Fabiano, Micheletto, Claudio, Vancheri, Carlo, Pedrini, Antonella, Addesi, Alice, Esposito, Immacolata, Martini, Nello

“…Chronic obstructive pulmonary disease (COPD) represents an important health challenge, despite being preventable and manageable thanks to up-to-date…”
Get full text

Lung cancer and interstitial lung diseases: the lack of prognostic impact of lung cancer in IPF by Carobene, Loredana, Spina, Donatella, Disanto, Maria Giulia, Micheletto, Claudio, Mazzei, Maria Antonietta, Paladini, Piero, Ghiribelli, Claudia, Bargagli, Elena, Rottoli, Paola

“…Lung Cancer (LC) is the first cause of death worldwide. Recently increased interest in interstitial lung diseases (ILD) has highlighted an association with…”
Get full text

Respiratory rate-oxygenation index on the 3rd day is the best predictor of treatment failure in COVID-19 patients by Raimondi, Federico, Centanni, Stefano, Luppi, Fabrizio, Aliberti, Stefano, Blasi, Francesco, Rogliani, Paola, Micheletto, Claudio, Contoli, Marco, Sanduzzi Zamparelli, Alessandro, Bocchino, Marialuisa, Busatto, Paolo, Novelli, Luca, Pappacena, Simone, Malandrino, Luca, Lorini, Giorgio, Cairoli, Greta, Di Marco, Fabiano

“…Predictors of outcomes are essential to identifying severe COVID-19 cases and optimizing treatment and care settings. The respiratory rate-oxygenation (ROX)…”
Get full text

Correction to: Lung cancer and interstitial lung diseases: the lack of prognostic impact of lung cancer in IPF by Carobene, Loredana, Spina, Donatella, Disanto, Maria Giulia, Micheletto, Claudio, Mazzei, Maria Antonietta, Paladini, Piero, Ghiribelli, Claudia, Bargagli, Elena, Rottoli, Paola

Get full text

How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center by Pasello, Giulia, Menis, Jessica, Pilotto, Sara, Frega, Stefano, Belluomini, Lorenzo, Pezzuto, Federica, Caliò, Anna, Sepulcri, Matteo, Cernusco, Nunzia Luna Valentina, Schiavon, Marco, Infante, Maurizio Valentino, Damin, Marco, Micheletto, Claudio, Del Bianco, Paola, Giovannetti, Riccardo, Bonanno, Laura, Fantoni, Umberto, Guarneri, Valentina, Calabrese, Fiorella, Rea, Federico, Milella, Michele, Conte, PierFranco

“…The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have…”
Get full text

Targeting eosinophils in allergic bronchopulmonary aspergillosis: is it effective as a steroid-sparing strategy? by Caminati, Marco, Festi, Giuliana, Micheletto, Claudio, Guidolin, Lucia, Todesco, Mattia, Lunardi, Claudio, Gianenrico, Senna

Get full text

Effects of anti‐IL5 biological treatments on blood IgE levels in severe asthmatic patients: A real‐life multicentre study (BIONIGE) by Contoli, Marco, Santus, Pierachille, Menzella, Francesco, Rocchi, Cindy, Radovanovic, Dejan, Baraldi, Federico, Martelli, Chiara, Casanova, Serena, Barbetta, Carlo, Micheletto, Claudio, Scichilone, Nicola, Beghè, Bianca, Carpagnano, Elisiana, Papi, Alberto

“…Background Mepolizumab and benralizumab are clinically effective biological treatments for severe eosinophilic asthmatic patients by hampering eosinophilic…”
Get full text

Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach by Caminati, Marco, Carpagnano, Lucia Federica, Alberti, Chiara, Amaddeo, Francesco, Bixio, Riccardo, Caldart, Federico, De Franceschi, Lucia, Del Giglio, Micol, Festi, Giuliana, Friso, Simonetta, Frulloni, Luca, Gisondi, Paolo, Krampera, Mauro, Lippi, Giuseppe, Micheletto, Claudio, Piacentini, Giorgio, Pinter, Patrick, Rossini, Maurizio, Schiappoli, Michele, Tecchio, Cristina, Tenero, Laura, Tinazzi, Elisa, Senna, Gianenrico, Carlucci, Matilde

“…Hypereosinophilic syndromes (HES) represent a group of rare dis-immune conditions characterized by blood hyper-eosinophilia and eosinophilic related burden…”
Get full text

Antimicrobial Stewardship in COVID-19 Patients: Those Who Sow Will Reap Even through Hard Times by Sibani, Marcella, Canziani, Lorenzo Maria, Tonolli, Chiara, Armellini, Maddalena, Carrara, Elena, Mazzaferri, Fulvia, Conti, Michela, Save Working Group, Mazzariol, Annarita, Micheletto, Claudio, Dalbeni, Andrea, Girelli, Domenico, Tacconelli, Evelina

“…Since the SARS-CoV-2 pandemic emerged, antimicrobial stewardship (AS) activities need to be diverted into COVID-19 management. In order to assess the impact of…”
Get full text

ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments by Lombardi, Carlo, Asero, Riccardo, Bagnasco, Diego, Blasi, Francesco, Bonini, Matteo, Bussi, Mario, Canevari, Rikki F., Canonica, Giorgio Walter, Castelnuovo, Paolo, Cecchi, Lorenzo, Cosmi, Lorenzo, Gelardi, Matteo, Heffler, Enrico, Indinnimeo, Luciana, Landi, Massimo, Licari, Amelia, Liotta, Francesco, Macchi, Alberto, Malvezzi, Luca, Marseglia, Gianluigi, Micheletto, Claudio, Musarra, Antonino, Peroni, Diego, Piacentini, Giorgio, Poletti, Venerino, Richeldi, Luca, Santoni, Angela, Schiappoli, Michele, Senna, Gianenrico, Vaghi, Adriano, Villani, Alberto, Passalacqua, Giovanni

“…In the recent years, it was recognized that type-2 inflammation links many forms of nasal polyposis with severe asthma. Thus, some biological drugs developed…”
Get full text

Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective by Caminati, Marco, Maule, Matteo, Benoni, Roberto, Bagnasco, Diego, Beghè, Bianca, Braido, Fulvio, Brussino, Luisa, Cameli, Paolo, Candeliere, Maria Giulia, Carpagnano, Giovanna Elisiana, Costanzo, Giulia, Crimi, Claudia, D'Amato, Mariella, Del Giacco, Stefano, Guarnieri, Gabriella, Yacoub, Mona-Rita, Micheletto, Claudio, Nicola, Stefania, Olivieri, Bianca, Pini, Laura, Schiappoli, Michele, Vaia, Rachele, Vianello, Andrea, Visca, Dina, Spanevello, Antonio, Senna, Gianenrico

“…Dupilumab is currently approved for the treatment of Type 2 severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP). Few studies have specifically…”
Get full text

Low adherence to inhaled corticosteroids/long-acting β2-agonists and biologic treatment in severe asthmatics by Caminati, Marco, Vianello, Andrea, Andretta, Margherita, Menti, Anna Michela, Tognella, Silvia, Degli Esposti, Luca, Micheletto, Claudio, Bovo, Chiara, Senna, Gianenrico

“…Eligibility criteria for a biologic treatment for severe asthma include poor disease control despite a full medication plan according to Global Initiative for…”
Get full text